Comorbidity of Depression and Anxiety: Association with Poor Quality of Life in Type 1 and 2 Diabetic Patients
Ana Claudia C. de Ornelas Maia1, *, Arthur de Azevedo Braga1, Flávia Paes1, Sergio Machado1, 2, 3, 4, Mauro Giovanni Carta5, Antonio Egidio Nardi1, Adriana Cardoso Silva1
1 Laboratory of Panic and Respiration –Institute of Psychiatry of Federal University of Rio de Janeiro, Rio de Janeiro – Brazil, National Institute of Translational Medicine (INCT-TM), Brazil
2 Institute of Phylosophy, Federal University of Uberlândia, Minas Gerais – Brazil
3 Quiropraxia Program of Faculty of Medical Sciences, Central University (UCEN), Santiago, Chile
4 Salgado de Oliveira University, Niterói, Brazil
5 Department of Public Health and Clinical and Molecular Medicine, University of Cagliari, Italy
Diabetes is associates with depression and impairment in Quality of Life (QoL).
The objective is to define the frequencies of depressive and anxiety symptoms in a sample of patients diagnosed with type 1 and 2 diabetes, the amount of impairment of QoL and the weight of depression and anxiety in determining the QoL in such of patients.
A total of 210 patients were divided into two groups (type 1 and type 2). Patients completed the HADS and WHOQoL-bref.
Groups showed a high prevalence of anxiety (type 1 = 60%, type 2 = 43.8%) and depression (type 1 = 52.4%, type 2 = 38.1%), both measures were significantly higher (p < 0.05) in diabetes type 1 patients. Type 1 patients also showed a QoL in the overall assessment and the physical, psychological and social relations domains. In both Type 1 and 2 diabetes poor QoL was found associated by anxiety and depression comorbidity.
In overall diabetes patients depression and anxiety seems to be a determinant of poor QoL.
Keywords: : Anxiety, depression, quality of life, type 1 and type 2 diabetes.
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the
work is properly cited.
* Address correspondence to this author at the Panic and Respiration Laboratory – Institute of Psychiatry of Federal University of Rio de Janeiro (IPUB/UFRJ), Brazil; E-mail: email@example.com